RESEARCH-USE BIOSIMILAR ANTIBODY
Itepekimab
Monoclonal antibody · IgG4
Itepekimab (REGN-3500) is an IgG4 monoclonal antibody against IL-33. Itepekimab reduced airway inflammation and related tissue damage in preliminary clinical studies. Itepekimab has potential effects in asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis (AD).
TARGETIL33
YMonoclonal antibody
CATALOGSC-BS-463
CATALOG NUMBERSC-BS-463
MOLECULAR WEIGHTApprox. 144.64 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Itepekimab (REGN-3500) is an IgG4 monoclonal antibody against IL-33. Itepekimab reduced airway inflammation and related tissue damage in preliminary clinical studies. Itepekimab has potential effects in asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis (AD).
Itepekimab is a recombinant research-use antibody directed against IL33.